Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...
The use of human papillomavirus (HPV) DNA testing as an initial screening step followed by triage with a standard Pap test (cytology) and repeat HPV DNA testing may increase the accuracy of cervical ...
Combining high-risk human papillomavirus (hrHPV)–based screening with cytologic triage detected two times more cases of grade 2+ cervical intraepithelial neoplasia (CIN2+) than cytology alone, ...
Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV ...
The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...
Cervical cancer is among the easiest gynecologic cancers to prevent, and two screening tests can help detect the disease early: the routine Pap smear and testing for human papillomavirus, or HPV. The ...
EL MUNDO on MSN
A menstrual blood test can detect the papillomavirus
The test could serve as an alternative in cervical cancer screening, cytology, according to a new study. Certain types of ...
A urine cytology test looks at the cells in your urine under a microscope. It can help your doctor diagnose some forms of urinary tract cancer. You may need one if you've had blood in your urine.
Human papillomavirus (HPV) DNA testing is the best cervical cancer screening option for all women over the age of 30, detecting the lesions which lead to cervical cancer earlier and preventing more ...
The most recent report published by Market Research Inc. indicates that the Cytology and HPV Testing Market is likely to accelerate significantly in the next few years. Specialists have studied market ...
IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results